by Sue Robbins | Jul 30, 2020 | Migraine
Phase 3 ADVANCE trial evaluating atogepant meets primary endpoint of statistically significant reduction from baseline in mean monthly migraine days, compared to placebo, for all doses evaluated across a 12-week treatment period – Trial also...
by Sue Robbins | Jul 28, 2020 | Migraine
In patients with episodic migraine, erenumab provided sustained efficacy for the condition over the course of 1 year, according to new results from a study to evaluate the efficacy and safety of erenumab in migraine prevention (STRIVE), published in Neurology....
by Sue Robbins | Jul 27, 2020 | Miscellaneous
What is a migraine? A migraine is a headache characterized by a throbbing sensation on one side of the head and sometimes other symptoms such as nausea, light-headedness and sensitivity to light and sound. Migraines can interfere with day-to-day life and symptoms may...
by Sue Robbins | Jul 22, 2020 | Migraine
Positive genetic correlations of migraine with diastolic blood pressure (BP) and systolic BP exist, supporting the notions that diastolic BP plays a critical role in migraine susceptibility and BP and migraine share underlying biological mechanisms, according to...
by Sue Robbins | Jul 16, 2020 | Migraine
Insufficient response to triptans is associated with poor health-related quality of life (HRQoL) and lower work productivity in migraineurs compared with those who respond well to the medications, according to a study published in The Journal of Headache and Pain....
